Paul A. Giusti
President and Chief Executive Officer
Paul Giusti is the President and Chief Executive Officer of the Multiple Myeloma Research Foundation (MMRF), a world-renown cancer-research organization. Prior to the MMRF, Mr. Giusti worked as a Chief Executive Officer, leader, executive and entrepreneur for over 30 years; he has founded, managed and led a variety of businesses. Early in his career, Mr. Giusti worked as an executive for GE where he held a number of management positions with a wide range of responsibilities.
Mr. Giusti has worked closely with the MMRF since its founding in 1998. In addition to chairing the successful $100 million capital campaign, he has served as a consultant for a number of foundation projects, led several MMRF outreach efforts and spoken on behalf of the MMRF.
Mr. Giusti holds a Bachelor of Science degree from the Colorado School of Mines and an MBA from Harvard University.
Chief Financial Officer
Rob Miani joined the MMRF team as Chief Financial Officer in 2016. Most recently he was the Vice President of Finance and Corporate Controller of Aptuit, LLC, a global contract research organization providing integrated early discovery to mid-phase drug development services in the pharmaceutical industry.
Rob has over 20 years of leadership experience in the private and public sectors, holding managerial positons in the renewable energy, private equity, Internet and technology industries, including Davenport Newberry, Oak Investment Partners and INT Media Group. He began his career with Arthur Anderson LLP in the Assurance and Business Advisory Services Division. Rob is a CPA and received his BS degree in Accounting from Fairfield University.
Daniel Auclair, PhD
Senior Vice President of Research
Dr. Daniel Auclair, who managed the MMRF Multiple Myeloma Genomics Initiative from 2007-2010, has rejoined the company after three years at the Broad Institute of MIT and Harvard.
As senior leader in the Cancer Program at the Broad Institute, Dr. Auclair was involved with a wide range of academic and industry collaborations centered around cancer genomics and personalized medicine.
Prior to this, he spent a decade in the pharmaceutical industry, most notably at Bayer Healthcare where he led a number of cancer drug discovery efforts.
Dr. Auclair has been involved in cancer genomics efforts and drug discovery for more than 20 years. He has been honored as one of the 2017 PharmaVOICE 100. The PharmaVOICE 100 is an annual list of inspirational and innovative individuals recognized for their positive contributions to the life-sciences industry. He has been recognized for his ability to act as a “bridge across the Cancer Archipelago” fostering collaboration in myeloma advancements among academia, government agencies and pharma companies.
Dr. Auclair holds graduate and post-graduate degrees in Biochemistry and Nutrition from the University of Montreal and conducted postdoctoral studies at the Dana-Farber Cancer Institute/Harvard Cancer Center.
Vice President of Events
Laura Gilman is the Vice President of Events at the MMRF where she manages the entire events portfolio. Prior to joining the MMRF in 2010 Ms. Gilman was the Vice President of Citigroup’s Investment Research Conferences where she directed the design and execution of the bank’s high profile research conferences and events. Before joining Citigroup, Ms. Gilman was the Director of Meetings, Client Relations and Incentives at Victoria’s Secret Beauty. She began her career at Morgan Stanley managing the bank’s IPO Roadshows. Ms. Gilman has over 20 years of experience designing and executing events and initiatives that generate revenue. She received her B.A. in English Literature from the Catholic University of America and lives in Westport, CT with her husband and son.
Vice President of Development
Richard Galiette was named Vice President of Development at the MMRF in 2017 responsible for philanthropic engagement for the foundation. Most recently, Mr. Galiette served as Senior Director of Development at Quinnipiac University where he successfully led development efforts for the new Center for Medicine, Health Sciences and Nursing, the School of Business, and the new School of Engineering.
Prior to Quinnipiac, Mr. Galiette spent 10 years at Yale University responsible for leadership giving as Associate Director of Major Gifts and Director of Development for Clinical Medicine at the Yale School of Medicine. He managed development efforts in Internal Medicine, Ophthalmology, Stem Cell, Urology and Orthopedics during the “Yale Tomorrow Campaign,” which raised 3.8 billion.
Prior to Yale, Mr. Galiette held senior sales positions within the healthcare and technology verticals and brings over 20 years of experience in leadership, business and strategic nonprofit fundraising. He holds a Bachelor of Arts degree from Saint Anselm College. He lives in Western Connecticut with his wife and two children.
Anne Quinn Young, MPH
Senior Vice President, Marketing & Communications
Anne Quinn Young, MPH, is Senior Vice President, Marketing & Communications at the MMRF where she leads brand strategy and execution of marketing and communications efforts across channels, as well as oversees the development of educational programming for patients and healthcare professionals to drive patient engagement in the Foundation’s mission. Anne joined the MMRF in 2002 to lead these efforts, but spent the last three years building out the Foundation’s Development department as the Vice President of Development.
Prior to joining the MMRF, she was a consultant in the Healthcare Practice of Datamonitor, a global market research and business intelligence company. She previously worked in healthcare public relations at Burson-Marsteller and the Chandler Chicco Agency, following a postgraduate internship at the Department of Justice, Antitrust Division.
Anne has a Master of Public Health from the Mailman School of Public Health of Columbia University and graduated cum laude from Dartmouth College with a Bachelor of Arts in Government.
Vice President of Business Development
Christopher Williams was named Vice President of Business Development at the MMRF in 2017 responsible for business development, partnership and joint venture efforts for the foundation. He is a business development leader with a strong scientific background, specializing in the pharmaceutical and diagnostics space. Most recently he served as the VP of Business Development at WaveSense where he was in charge of their US commercialization strategy and product expansion, as well as, being responsible for overseeing their strategic partner relationships.
Previously Chris was VP of Business Development at SkylineDx providing commercialization strategy for their oncology portfolio. With PerkinElmer, as the Market Segment Leader in Oncology he had responsibility for their cancer diagnostic products including strategy, launch activities, external presentations and marketing execution.
While at Millennium Pharmaceuticals Chris held roles in the Protein Science, Technology Development and Proteomics groups. He also had scientific roles at Schering-Plough and the Sandoz Research Institute.
Chris holds graduate and post-graduate degrees in Microbiology/Molecular Biology and Protein Biochemistry from Clemson University.